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Abstract: AflatoxinM1 (AFM1) is an importantmycotoxin frequently found inmilk and in dairy products. It
is a minor metabolic product of Aspergillus flavus and A parasiticus. However, it occurs in dairy products
as a metabolite formed in cows from aflatoxin B1 contained in animal feeds. In cheese production, AFM1
distributes between curd and whey, being present in products derived from cheese whey processing.
In this study, cheese whey from dairy processing was artificially contaminated with the mycotoxin at
about 0.1 µg l−1. Ultra-filtration experiments of whey were carried out in order to determinate AFM1
distribution between retentate (protein-rich fraction) and permeate (lactose-rich fraction). Recoveries of
AFM1 in retentate were 72.6–86.4% while, in permeate, recoveries were in the range 2.4–14.7%. Partition
coefficients of AFM1, lactose and protein were calculated to determine whether there was an interaction
between AFM1 and protein. In all experiments, AFM1 partition coefficient was lower than 1, whilst for
lactose coefficients close to 1 were determined, showing an affinity of aflatoxin M1 to the protein-rich
fraction (retentate).
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INTRODUCTION
Aflatoxins are a group of naturally occurring toxins
which are secondary metabolites of some Aspergillus
spp. Aflatoxin M1 (AFM1) is a very important toxin in
milk and dairy products and is a minor metabolic
product of Aspergillus flavus and A parasiticus.1
However, it apparently occurs mainly in dairy products
as a transformation product of cows of the aflatoxin
B1 contained in animal feeds. Thus, AFM1 represents
a potential hazard to humans via consumption of
milk and milk products.2 AFM1 is less mutagenic3
and carcinogenic4 than AFB1 but it exhibits high
genotoxic activity.5,6 The maximum admissible level of
this mycotoxin in raw milk, heat-treated milk and milk
for manufacture of milk-based products7 range from
0.05 µg kg−1, in the EU, to 0.5 µg kg−1, in the USA.
In cheese processing, two products are derived
from milk: cheese and cheese whey: cheese (curd)
represents about 10% of the initial mass of milk, the
remaining being cheese whey. According to the review
of Galvano et al,2 several studies on the partitioning of
AFM1 during cheese manufacture report a wide range
of distribution of AFM1 between whey and curd.
Some authors observed that 50–100% of the AFM1
was in whey. In contrast, others report that most
of AFM1 was in curd (66–100%). These authors
refer as possible explanations (1) differences in the
methodology for AFM1 determination, (2) type and
degree of milk contamination, (3) differences in the
expression of results, or (4) differences in the cheese
manufacture process. In addition, Applebaum et al
(cited by Bakirci8) report that, since AFM1 is a semi-
polar component, it has less affinity to serum protein,
this being the reason for the lower levels of AFM1
found in cheese whey than in the original milk used
for cheese manufacturing.
Whey is an important by-product from the cheese
manufacturing industry. Disposal of liquid whey is
costly due to its high biochemical oxygen demand
(BOD) content. Utilization of whey protein products
is dependent upon increasing the solids content and
reducing the ratio of lactose to protein. Ultra-filtration
is used to simultaneously fractionate, purify, and
concentrate liquid whey for whey protein powder
(WPC), which may be accomplished by single or
multiple stage continuous processes.9 Ultra-filtration
membranes used for whey protein concentration
normally have a molecular weight cut-off in the range
10–50 kDa and readily pass lactose and minerals,
but reject proteins and residual milkfat.9 Since whey
proteins have a number of useful nutritional and
functional properties, WPC can be used in a wide
range of commercial products, such as food additives,
or may be fractionated into individual whey proteins.9
All these products may contribute for AFM1 intake.
The aim of this work was to study the distribution
of aflatoxin M1 through the retentate and permeate
when whey ultra-filtration is carried out. The ultra-
filtration permeate contains mainly low molecular
weight constituents, such as lactose, acids and ash,
and the retentate contains mainly proteins.
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EXPERIMENTAL
Cheese whey powder was obtained from a dairy
processing plant. This whey product was produced
from defatted sweet cheese whey, by spray drying.
Bovine serum albumin (BSA; minimum 98%) and
AFM1 stock solution were obtained from Sigma
(Lisbon). HPLC grade solvents were delivered from
Merck (Lisbon).
Cheese whey reconstitution
Cheese whey was reconstituted to the desired
concentration (7, 8 or 10% w/v) by dissolving the
appropriate amount of powder in double-distilled
water. AFM1 contamination was accomplished by the
addition of an accurate volume of a 500 µg l−1 AFM1
standard solution in methanol. The final spiked AFM1
concentration was 0.1 µg l−1.
Ultra-filtration experiments
Ultra-filtration experiments were performed using a
Pellicon XL filter with membrane Biomax 10
(Millipore Ibe´rica SA, Madrid), with a cut-off of
10 kDa. Reconstituted cheese whey (feed) (500 ml)
was pumped with a peristaltic pump at a flow rate of
48 ml min−1 to the ultra-filtration unit, the permeate
and the retentate being collected in different graduate
containers for volume measurement. With these
volumes, and corresponding AFM1 concentrations,
a material balance was performed to calculate the
recovery of the mycotoxin in each fraction. Control of
the flow rate of permeate was made by adjusting the
pressure at the retentate outlet.
After a first stage in the operation of the ultra-
filtration membrane as described above, diafiltration
stages were conducted by adding double-distilled
water to the retentate in equal volume of the permeate
that was collected from the previous filtration.
Permeate and retentate were collected as mentioned
before.
Solids determination
In order to determinate the dry extract of solids in feed,
retentate and permeate, a refractometer (Leica DC 60;
El Paso, USA) was used. A calibration curve was made
using solutions in the range 0–100 g l−1 of dried whey
powder in water, and a linear regression (r2 = 0.99)
was obtained between dry extract and refractive index.
Protein determination
Protein was determined by the method of Bradford.10
Working solutions containing 0.02–1 mg l−1 of BSA
were prepared in order to construct a calibration curve.
Aliquots of protein solution (10 µl) were added to
290 µl of Coomassie reagent in a microplate. After
20 min the absorbance at 595 nm was read in a Spectra
& Rainbow Tecan instrument (Salzburg, Austria).
Protein was determined in the inlet (feed) and in
the two outlets (retentate and permeate) of the ultra-
filtration unit. The protein partition coefficient (Kp)
was determined as the ratio between the protein
concentration in permeate and in retentate.
Lactose determination
Lactose content was determined using the enzymatic
kit lactose/D-galactose UV method of Boehringer
Mannheim. Lactose was determined in the feed, in
retentate and in permeate. Its partition coefficient
(KL) was determined again as the ratio between its
concentration in permeate and in retentate.
Aflatoxin M1 determination
Immunoaffinity clean-up
Aflatoxin M1 was determined in the feed, in retentate
and in permeate as reported by Tuinstra et al.11
Samples of these three solutions were centrifuged
at 2500 × g for 15 min and then filtered through a
glass microfibre filter (1.6-µm pore size) in order
to collect a 25-ml volume sample that was passed
through an immunoaffinity column (Aflaprep M, R-
Biopharm Rhone Ltd, Glasgow, Scotland, UK). The
unbound components were washed twice with 10 ml
of distilled water. Elution was done using 1.25 ml of
methanol:acetonitrile (20:30) at a flow rate of one drop
every 2–3 s. A further 1.25 ml of distilled water was
passed through the column resulting in a final eluate
volume of 2.5 ml. This eluate was analyzed directly by
HPLC.
To perform recovery assays, reconstituted whey
was artificially contaminated with AFM1 at level of
0.1 µg l−1. Analytical recovery average for this method
was 98% (CV = 3.3%, n = 3).
HPLC quantification
In order to construct a calibration curve, standard
working solutions containing 0.1–2 µg l−1 AFM1 in
mobile phase were prepared from a ready-to-use
aflatoxin M1 standard solution (500 µg l−1; Sigma-
Aldrich, Lisbon, Portugal) in methanol. A calibration
curve was obtained by linear regression of the least-
squares method using peak height of the standard
as response. The correlation coefficient was higher
than 0.999. The limit of detection was 0.04 µg l−1,
as calculated from the sum of intercept and three
times the standard deviation of the y-residuals of the
calibration graph. Therefore, the limit of detection in
whey samples was 0.004 µg l−1.
Determination of AFM1 was carried out by reverse-
phase HPLC11 equipped with a Jasco FP-920 flu-
orescence detector (360 nm excitation wavelength;
430 nm emission wavelength). Chromatographic sep-
arations were performed on a Waters Spherisorb
ODS2 (4.6 mm × 250 mm; 5 µm) column, fitted
with a pre-column with the same stationary phase
operated at 30 ◦C. The mobile phase used was
pumped at 1.0 ml min−1 and consisted of an isocratic
programme as follows: water:acetonitrile:methanol
(68:24:8, v/v/v). The injection volume was 100 µl.
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Aflatoxin M1 partition coefficient (KAFM), was
determined as the ratio between its concentration in
permeate and in retentate.
RESULTS AND DISCUSSION
The AFM1 concentrations in cheese whey loaded to
the ultra-filtration unit (feed) and in both solutions
coming out of the same unit (retentate and permeate)
were determined (Table 1). The recovery of AFM1 in
permeate and retentate fractions was also calculated
(Table 1). Partition of total protein, lactose and AFM1
between permeate and retentate in the ultra-filtration
of cheese whey was determined (Table 2).
AFM1 was found to favour the retentate fraction,
where high molecular weight compounds, such as
proteins, are expected to be concentrated. Data
in Table 1 show a higher concentration of AFM1
in retentate than in permeate for all experiments.
Recoveries of AFM1 in retentate were in range
72.6–86.4%, while in permeate the range varied
between 2.4 and 14.7% (Table 1). These results
suggest that AFM1 is transferred preferentially to
the protein rich fraction, although being a low
molecular weight (328.3 g mol−1) compound. Total
mean recovery of 87.4% was obtained. This small loss
in AFM1 could be due to fouling in the membrane.
The affinity of AFM1, lactose and total protein
to permeate and retentate was assessed by the
determination of their partition coefficients between
these fractions.
For the assay using 7% w/v whey powder, lactose
partition coefficient (KL) was determined and found
to be near unity (Table 2), meaning that there is
similar distribution of lactose between permeate and
retentate, which is the common behaviour of lactose
in industrial-scale cheese whey ultra-filtration.9,12
However, AFM1 and total protein partition coeffi-
cients, KAFM and KP, respectively, were found to be
much lower than one. The very low values reported
for KP were expected, since the molecular weights of
these compounds do not allow them to be present in
the permeate. Only a small fraction of some small pep-
tides, originated from the hydrolysis of casein proteins
during cheese making, were expected to be present in
the permeate, and explain the small values of protein
concentration that were reported in this fraction.
Partition coefficients of AFM1 shown in Table 1
cannot be explained based on its molecular weight.
This mycotoxin has a molecular weight of the
same order as lactose: 328.3 and 442 g mol−1,
respectively. In the absence of any interaction with
other compounds present in cheese whey, aflatoxin
M1 should partitioned like lactose between permeate
and retentate. The higher affinity of AFM1 for the
retentate fraction can be due to an interaction between
this mycotoxin and proteins.
The concentration of AFM1 in permeate does not
differ from its concentration in the original whey.
However, since this retentate has a lower lactose
content, it is expected that after drying it will originate
a higher AFM1 concentration in WPC than in the
original whey protein powder.
Table 1. Aflatoxin M1 distribution between retentate and permeate
Retentate Permeate
Feed
Dried whey powder (% w/v) Stagea Aflatoxin M1 (µg l−1) Aflatoxin M1 (µg l−1) Recovery (%) Aflatoxin M1 (µg l−1) Recovery (%)
10 UF 0.098 0.094 80.2 0.015 2.4
DF 0.076 0.077 86.4 0.025 5.1
8 UF 0.096 0.089 72.6 0.029 6.5
DF 0.066 0.069 85.5 0.031 8.6
DF 0.055 0.058 84.4 0.033 12.0
7 UF 0.097 0.089 73.0 0.026 5.5
DF 0.068 0.067 76.4 0.033 10.9
DF 0.050 0.049 74.8 0.031 14.7
a Stage: UF = ultra-filtration; DF = diafiltration.
Table 2. Ratio between aflatoxin M1 concentration (KAFM), lactose concentration (KL) and protein concentration (KP) in permeate and in retentate
Dried whey powder (% w/v) Stagea Aflatoxin M1 (KAFM) Lactose (KL) Protein (KP)
10 UF 0.16 nd 0.03
DF 0.33 nd 0.04
8 UF 0.33 nd 0.05
DF 0.44 nd 0.03
DF 0.56 nd 0.03
7 UF 0.29 0.94 0.09
DF 0.49 1.14 0.05
DF 0.64 0.99 0.05
nd = not determined
a Stage: UF = ultrafiltration; DF = Diafiltration
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CONCLUSIONS
The fate of AFM1 during cheese whey fractionation
by ultra-filtration was assessed. Based on its molecular
weight, and in the absence of interactions with
other whey components, it was expected that AFM1
would permeate through the membrane together
with other low molecular weight components of
cheese whey, such as lactose. Under the experimental
conditions used in this work, lactose distributes
evenly between permeate and retentate, whilst AFM1
exhibits a preference for the retentate. This behavior,
which is not explained by its molecular weight,
could be due to an interaction with the protein
content in this fraction. This interaction apparently
contradicts the low affinity of AFM1 for serum
proteins cited by Bakirci.8 However, Dosako et al13
report that this affinity for serum proteins is lower
when compared to its affinity for caseins. Since
the latter are almost absent from cheese whey, an
interaction between AFM1 and serum proteins can
occur.
These results suggest that the production of whey
protein powder by ultra-filtration could lead to a higher
concentration of AFM1 than in the original whey.
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